BUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA

Reuters10-04

** Shares of Neurotech International fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold

** The biopharmaceutical development firm says the US Food and Drug Administration (FDA) denied request for use of co's medicine in children and adults

** Stock hits its lowest level since Aug. 30, 2023

** 1.9 mln shares change hands, compared with the 30-day average volume of 846,268

** Stock has lost over 13% so far this week

** Stock is down 26% YTD as of 0121 GMT

(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2472867274?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-04 09:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472867274","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA","media":"Reuters","content":"<html><body><p>** Shares of Neurotech International    fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold</p><p>   ** The biopharmaceutical development firm says the US Food and Drug Administration (FDA) denied request for use of co's medicine in children and adults</p><p>   ** Stock hits its lowest level since Aug. 30, 2023</p><p>   ** 1.9 mln shares change hands, compared with the 30-day average volume of 846,268</p><p>   ** Stock has lost over 13% so far this week</p><p>   ** Stock is down 26% YTD as of 0121 GMT</p><p> (Reporting by Rajasik Mukherjee in Bengaluru)</p><p>((Rajasik.Mukherjee@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-04 09:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of Neurotech International    fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold   ** The biopharmaceutical development firm says the US Food and ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NTI.AU","symbol_name":"NEUROTECH INTERNATIONAL LTD","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2472867274","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472867274","pubTimestamp":1728005361,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of Neurotech International    fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold   ** The biopharmaceutical development firm says the US Food and Drug Administration  denied request for use of co's medicine in children and adults   ** Stock hits its lowest level since Aug. 30, 2023   ** 1.9 mln shares change hands, compared with the 30-day average volume of 846,268   ** Stock has lost over 13% so far this week   ** Stock is down 26% YTD as of 0121 GMT ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NTI.AU":"NEUROTECH INTERNATIONAL LTD","BK7007":"医疗保健设备"},"translate_title":"BUZZ-澳大利亚神经技术公司因美国FDA拒绝药物申请而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NTI.AU":0.9},"content_text":"** Shares of Neurotech International    fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold   ** The biopharmaceutical development firm says the US Food and Drug Administration (FDA) denied request for use of co's medicine in children and adults   ** Stock hits its lowest level since Aug. 30, 2023   ** 1.9 mln shares change hands, compared with the 30-day average volume of 846,268   ** Stock has lost over 13% so far this week   ** Stock is down 26% YTD as of 0121 GMT (Reporting by Rajasik Mukherjee in Bengaluru)((Rajasik.Mukherjee@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472867274"}